Case Study: A Novel Bacterial Contamination in Cell Culture Production—Leptospira licerasiae

References

1. 1.↵
   1. Ellinghausen H. C.,
   2. McCullough W. G

   . Nutrition of Leptospira pomona and growth of 13 other serotypes: fractionation of oleic albumin complex (OAC) and a medium of bovine albumin and polysorbate 80. Am. J. Vet. 1965, 26, 45–51.

   OpenUrlGoogle Scholar
2. 2.↵
   1. Johnson R. C.,
   2. Harris V. G

   . Differentiation of pathogenic and sparophytic leptospires. I. Growth at low temperatures. J. Bacteriol. 1967, 94 (1), 27–31.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
3. 3.↵
   1. Kiss R

   . Practicing safe cell culture: applied process designs for minimizing virus contamination risk. PDA J. Pharm. Sci. Technol. 2011, 65 (6), 715–729.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
4. 4.↵
   1. Plank R.,
   2. Dean D

   . Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microb. Infect. 2000, 2 (10), 1265–1276.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
5. 5.↵
   1. Levett P. N

   . Leptospirosis. Clin. Microbiol. Rev. 2001, 14 (2), 296–326.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
6. 6.↵
   1. Matthias M. A.,
   2. Ricaldi J. N.,
   3. Cespedes M.,
   4. Diaz M. M.,
   5. Galloway R. L.,
   6. Saito M.,
   7. Steigerwalt A. G.,
   8. Patra K. P.,
   9. Ore C. V.,
   10. Gotuzzo E.,
   11. Gilman R. H.,
   12. Levett P. N.,
   13. Vinetz J. M

   . Human Leptospirosis caused by a new, antigenetically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl. Trop. Dis. 2008, 2 (4), 1–12.

   OpenUrlGoogle Scholar
7. 7.↵
   United States Pharmacopia 34. Chapter 〈85〉 Bacterial Endotoxins Test. 2011.

   Google Scholar
8. 8.↵
   1. Cinco M

   . New insight into the pathogenicity of leptospires: evasion of host defenses. New Microbiol. 2010, 33 (4), 283–292.

   OpenUrlPubMedGoogle Scholar
9. 9.↵
   1. Johnson R. C.,
   2. Gary N. D

   . Nutrition of Leptospira pomona II. Fatty acid requirements. J. Bacteriol. 1963, 85 (5), 976–982.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
10. 10.↵
    1. Henneberry R. C.,
    2. Cox C. D

    . Beta-oxidation of fatty acids by Leptospira. J. Gen. Microbiol. 1970, 16 (1), 41–45.

    OpenUrlGoogle Scholar
11. 11.↵
    1. Murphy P. A

    . Clinical conference at the Johns Hopkins Hospital. J. Hopkins Med. J. 1980, 147, 65–69.

    OpenUrlGoogle Scholar
12. 12.↵
    1. Johnson R. C.,
    2. Harris V. G.,
    3. Walby J. K

    . Characterization of leptospires according to fatty acid requirements. J. Gen. Microbiol. 1969, 55 (3), 399–407.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
13. 13.↵
    1. Falkow S.,
    2. Rosenberg E.,
    3. Stakenbrandt E.,
    4. Dworkin M

    1. Adler B.,
    2. Faine S

    . The Genus Leptospira. In Prokaryotes, 3rd ed.; Falkow S., Rosenberg E., Stakenbrandt E., Dworkin M , Eds.; Springer: New York, 2006; Vol. 7, pp 294–317.

    OpenUrlGoogle Scholar
14. 14.↵
    1. Kefford B.,
    2. Marshall K. C

    . Adhesion of Leptospira at a solid-liquid interface: a model. Arch. Microbiol. 1984, 138 (1), 84–88.

    OpenUrlPubMedGoogle Scholar
15. 15.↵
    1. Sundaram S.,
    2. Auriemma M.,
    3. Howard G. Jr..,
    4. Brandwein H.,
    5. Leo. F

    . Application of membrane filtration for removal of diminutive bioburden organisms in pharmaceutical products and processes. PDA J. Pharm. Sci. Technol. 1999, 53 (4), 186–201.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
16. 16.↵
    United States Pharmacopia 34. Chapter 〈61〉 Microbiological Examination of Nonsterile Sroducts: Microbial Enumeration Tests. 2011.

    Google Scholar
17. 17.↵
    United States Pharmacopia 34. Chapter 〈71〉 Sterility Tests. 2011.

    Google Scholar